US Supreme Court Examines Controversial Opioid Crisis Settlement
The Supreme Court is currently hearing oral arguments in a landmark bankruptcy case involving Purdue Pharma, the maker of OxyContin.
Stay updated with breaking news from Knoa Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Supreme Court is currently hearing oral arguments in a landmark bankruptcy case involving Purdue Pharma, the maker of OxyContin.
Many believe that the Sackler-owned company Purdue Pharma is responsible for igniting the opioid epidemic through its drug OxyContin.
On Monday, the Supreme Court will take on one of its highest-profile bankruptcy cases in recent memory: Whether or not to approve OxyContin-maker Purdue Pharma’s controversial agreement that would give billions of dollars to victims of the opioid epidemic while protecting members of the Sackler family, who owned the company, from current and future opioid-related civil lawsuits.
Purdue Pharma has said there will be no $6 billion opioid crisis settlement without releasing Sackler family members from liability
The justices will hear oral arguments on Monday.